由于获得的C1抑制剂缺乏而导致的血管的长期预防治疗
Mats de Lange1, Remy S Petersen1, Lauré M Fijen1
1Amsterdam UMC, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, the Netherlands.
The Journal of allergy and clinical immunology
|August 29, 2025
概括
在获得C1抑制剂缺乏症 (AAE-C1INH) 患者中,延长释放药片有效地预防了血管发作. 这种治疗在长期使用时没有安全问题,为治疗这种罕见疾病提供了新的选择.
科学领域:
- 药理学
- 免疫学
- 罕见疾病
背景情况:
- 获得的C1抑制剂缺乏症 (AAE-C1INH) 是一种罕见的疾病,由于勃拉迪基宁的过度产生,导致血管的复发.
- 一种B2受体抗剂Deucrictibant正在开发用于治疗遗传性血管.
- 之前的一项试验显示了deucrictibant在AAE-C1INH患者中的有效性.
研究的目的:
- 评估deucrictibant延长释放片的长期有效性和安全性,以预防AAE-C1INH患者的血管.
主要方法:
- 一项开放式单臂研究涉及AAE-C1INH患者,每天接受40mg延长释放片.
- 与基线相比,主要测量结果是每28天血管发作的减少.
主要成果:
- 纳入了四名AAE- C1INH患者,其中三名患者来自之前的试验.
- 患者每月血管发作显著减少,从基线平均1. 35降至治疗期间的0. 01.
- 在随访期间 (563-612天) 没有报告与治疗相关的不良事件.
结论:
- 在AAE-C1INH患者中,延长释放药片在预防血管发作方面表现出显著的有效性.
- 治疗耐受性良好,没有发现安全问题,这表明它具有长期预防治疗的潜力.
相关概念视频
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Depolarizing Blockers: Pharmocokinetics
377
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
377
Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
253
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
253
Endocarditis III: Medical Management
17
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
17


